Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Non-Squamous Non-Small Cell Neoplasm of Lung × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 970 Carcinoma, Non-Small-Cell Lung 609 Neoplasms 478 Prostatic Neoplasms 437 Colorectal Neoplasms 373 Multiple Myeloma 292 Lung Neoplasms 264 Neoplasm Metastasis 257 Leukemia, Myeloid, Acute 232 Carcinoma, Hepatocellular 221 Stomach Neoplasms 218 Ovarian Neoplasms 191 Rectal Neoplasms 184 Lymphoma 175 Lymphoma, Follicular 174 Colonic Neoplasms 173 Leukemia 163 Uterine Cervical Neoplasms 155 Pancreatic Neoplasms 153 Head and Neck Neoplasms 149 Lymphoma, Non-Hodgkin 147 Recurrence 143 Lymphoma, Large B-Cell, Diffuse 140 Leukemia, Lymphocytic, Chronic, B-Cell 139 Precursor Cell Lymphoblastic Leukemia-Lymphoma 137 Melanoma 135 Brain Neoplasms 126 Urinary Bladder Neoplasms 124 Squamous Cell Carcinoma of Head and Neck 123 Pain 121

Interventions

Pemetrexed 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03912389 2020-09-17

DOMAJOR

Biocad

Phase 3 Unknown

Non-Squamous Non-Small Cell Neoplasm of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡